.

News

Vesalius News

11/07/2025
Memo Therapeutics: Long Term Follow-Up Data
read more
11/07/2025
CatalYm‘s visugromab at SITC 2025
read more
10/20/2025
CatalYm: Long-Term Phase 1/2a Data
read more
.

xxnoxx_zaehler